Please assess the completion status of the following clinical trial:

Trial Title: Red Cell Transfusion Goals in Patients With Acute Leukemias

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Acute leukemia patients (AML, ALL, APL, treatment-related myeloid neoplasm, high grade MDS)~* Admitted with plans for inpatient myelosuppressive chemotherapy (with standard of care or protocol regimens)~Exclusion Criteria:~* Age less than 18 years~* Acute coronary syndrome as defined by active chest pain, dynamic ECG changes, troponin greater than 2.5~* Active blood loss~* Receiving erythropoietin stimulating agents prior to admission~* Chronic Renal Failure in Renal Replacement Therapy~* Documented wish against transfusion for personal or religious beliefs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Low transfusion threshold (Type: EXPERIMENTAL): Patients receive red blood cell transfusions with a transfusion threshold of 7 g/dL hemoglobin (Hb). Transfusions will not be given on schedule but will be given whenever Hb dips below the threshold.
- High transfusion threshold (Type: ACTIVE_COMPARATOR): Patients receive red blood cell transfusions with a transfusion threshold of 8 g/dL hemoglobin (Hb). Transfusions will not be given on schedule but will be given whenever Hb dips below the threshold.

Based on this trial design, predict the completion outcome and termination type (if applicable).